Back

Effect and safety of PCSK9 inhibitor in-hospital use on blood lipid level in the ACS patients: a systematic review and meta-analysis

13 April 2024 (08:30 - 17:40)
Organised by: Logo
Congress Presentation Part of: Poster session 2 Lipid Metabolism, Metabolic Syndrome, Diabetes CBS PREMIUM ACCESS Frontiers in CardioVascular Biomedicine 2024 Council on Basic Cardiovascular Science

About the speaker

Photo
Ms Dandan Li

Chinese PLA General Hospital, Beijing (China)

72 More presentations in this session

Presentation thumbnail
Characterization of senescence in human cardiac fibroblasts
Doctor A. Costa (Genoa, IT)
Abstract
Presentation thumbnail
Cardioprotective effect of cemtirestat treatment in male Zucker diabetic fatty rats: a pilot study.
Doctor T. Egan Benova (Bratislava, SK)
Abstract
Presentation thumbnail
Dynamic links between the cardiac intermediate filaments of the cytoskeleton and nucleoskeleton for proper cardiomyocyte differentiation, maturation and reprogramming.
Doctor M. Tsikitis (Athens, GR)
Abstract
Presentation thumbnail
Differential sex-dependent role of lncRNAs in cardiomyopathy
Professor D. Franco (Jaen, ES)
Abstract
Presentation thumbnail
MiR-92b-3p modulates apoptosis in smooth muscle cells through BCL2L11 regulation, unravelling novel therapeutic strategies for unstable plaques.
Mr J. Koester (Halle, DE)
Abstract

Access the full session

Session thumbnail
Poster session 2

The Event

Event poster

Frontiers in CardioVascular Biomedicine 2024

13 April 2024 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Early PCSK9 inhibitor subscription during episode of acute myocardial infarction (EPISODE-AMI) study
thumbnail
Congress Presentation
PCSK9 inhibitors and cardiovascular outcomes in AMI-BIRISK patients: a multicenter retrospective study
thumbnail
Congress Presentation
Does early initiation of non-statin therapy, evolocumab with LDL-C <50mg/dL contribute to the reduction of hospital readmissions in patients with ACS?: a single center real world evidence from ELAINE

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources